Yahoo Finance

Prometheus Laboratories Launches New Anser(R) Test for Risankizumab

SAN DIEGO, CA / ACCESS Newswire / April 1, 2025 / Prometheus Laboratories Inc. ("Prometheus"), a leader in precision-guided medicine, announces a new Anser® therapeutic drug monitoring (TDM) test for ...
GEN

Prometheus Chooses DNA Genotek Sample Collection Kit for MyCeliacID™ Genetic Test

Saliva-based diagnostic detects genes related to the disease and calculates risk. Prometheus has selected DNA Genotek’s Oragene®•DNA product as the sample-collection kit for MyCeliacID™, a ...
Yahoo Finance

Prometheus Laboratories Launches First Pre-Therapy Test to Predict Likelihood of Biologic Response

SAN DIEGO, CA / ACCESS Newswire / April 29, 2025 / Prometheus Laboratories Inc. ("Prometheus"), a leader in precision-guided medicine, announces the novel Responder TNF blood test is now commercially ...
Medindia

Prometheus Launches the First Serogenetic Test to Predict Risk of Complications From Crohn's Disease

SAN DIEGO, Aug. 31 Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced the commercial launch of its proprietary PROMETHEUS® Crohn's Prognostic test. This ...
Business Insider

Introducing PROMETHEUS® IBcause™: Convenient All-in-One Diagnostic Test for Persistent Diarrhea

SAN DIEGO, March 28, 2017 /PRNewswire/ -- Prometheus Laboratories Inc.—a Nestlé Health Science company—announces the launch of IBcause™, an all-in-one convenient test that evaluates a unique ...